Esophageal Adenocarcinoma Clinical Trials in Amsterdam
5 recruitingAmsterdam, Netherlands
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
Gastric CancerEsophageal AdenocarcinomaPancreatic Ductal Adenocarcinoma+1 more
AstraZeneca280 enrolled25 locationsNCT06005493
Recruiting
Phase 2
Metformin as a Metabolic Intervention in Oesophageal Adenocarcinomas to Improve Response to Neoadjuvant Chemoradiotherapy
Tumor MicroenvironmentOesophageal Adenocarcinoma
Amsterdam UMC, location VUmc14 enrolled2 locationsNCT06687876
Recruiting
Phase 2
Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus)
Esophageal AdenocarcinomaGastric Adenocarcinoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)25 enrolled8 locationsNCT05177133
Recruiting
Not Applicable
Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal Adenocarcinoma
Barrett EsophagusSubmucosal Esophageal AdenocarcinomaHigh-risk Mucosal Esophageal Adenocarcinoma
Amsterdam UMC225 enrolled20 locationsNCT03222635
Recruiting
Phase 3
TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancer
Esophageal CancerEsophageal Adenocarcinoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)376 enrolled1 locationNCT05188313